trial

The Effect of Transcranial Direct Current Stimulation on Human Brains: A Neuroimaging Study

NCTId NCT02421146
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 12 (actual)
Sponsored by Northwell Health, Early Treatment Program at Lenox Hill
Primary completion 2016-09-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
12 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2015-04
Primary completion
2016-09-12
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
transcranial direct current stimulation

Sponsors

Northwell Health, Early Treatment Program at Lenox HillLead Sponsor

Investigators

1
Miklos Argyelan, MDPrincipal Investigator

Sites

1 total
Glen Oaks, United States

Facts & assertions

4 sourced
Enrollment
12
Phase
NA
Primary Completion Date
2016-09-12
Status
COMPLETED
relationships
The graph out of here
drug
transcranial direct current stimulation
drug
lead_sponsor
Northwell Health, Early Treatment Program at Lenox Hill
company
indication
Chronic Schizophrenia
indication
investigator
Miklos Argyelan, MD
person